# Optimizing the Use of Ketamine to Reduce Chronic Postsurgical Pain

> **NCT05037123** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **NYU Langone Health** · enrollment: 765 (actual)

## Conditions studied

- Chronic Postsurgical Pain

## Interventions

- **DRUG:** Continuous ketamine infusion
- **DRUG:** Ketamine + Saline
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05037123
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-01-04
- **Primary completion:** 2025-05-28
- **Final completion:** 2026-08-31
- **Target enrollment:** 765 (ACTUAL)
- **Last updated:** 2026-05-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05037123

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05037123, "Optimizing the Use of Ketamine to Reduce Chronic Postsurgical Pain". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05037123. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*